Tianjun Zhou

Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase

Wei‐Sheng Huang, Shuangying Liu, Dong Zou et al. · Journal of Medicinal Chemistry · 2016 · 404 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models

Sen Zhang, Rana Anjum, Rachel M. Squillace et al. · Clinical Cancer Research · 2016 · 326 citations · Full text

Medicine, Oncology, Pharmacology +15

Ponatinib Inhibits Polyclonal Drug-Resistant KIT Oncoproteins and Shows Therapeutic Potential in Heavily Pretreated Gastrointestinal Stromal Tumor (GIST) Patients

Andrew P. Garner, Joseph M. Gozgit, Rana Anjum et al. · Clinical Cancer Research · 2014 · 160 citations

Medicine, Oncology, Pharmacology +15

Fragment Growing and Linking Lead to Novel Nanomolar Lactate Dehydrogenase Inhibitors

Anna Kohlmann, Stephan G. Zech, Feng Li et al. · Journal of Medicinal Chemistry · 2013 · 85 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +17

Highly Sensitive and Stable Flexible Sensors Based on Antifreezing and Self-Healing Double-Network Composite Hydrogels for Human Motion Monitoring

Pan Li, Tianjun Zhou, Liangjiu Bai et al. · ACS Applied Polymer Materials · 2023 · 14 citations

Natural Sciences, Materials Engineering, Materials Science +17